Cerner Achieves 500th Patent With Voice-Assisted Technology Print E-mail
By GLOBE NEWSWIRE   
Monday, 02 December 2019 11:13

KANSAS CITY, Mo., Dec. 02, 2019 (GLOBE NEWSWIRE)

KANSAS CITY, Mo., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN), a global health care technology company, has achieved its 500th patent, a new innovative voice-assisted technology designed to make it easier for clinicians to document the details of a patient visit on a mobile device. This milestone builds on Cerner’s legacy of technological advancement and industry-leading patent portfolio, validating the company’s rich 40-year history of transformation at the intersection of health care and technology.

Documentation becomes easier, faster and hands free with voice-assisted technology, bringing clinicians out from behind the keyboard and instead engaging directly with patients about their health. Cerner’s 500th patent expands its work in leveraging voice inputs and natural language processing to reduce the clinician’s documentation burden. The technology captures the verbal interaction between a clinician and patient to document the medical visit. Information relevant to the patient’s care is identified, extracted and presented directly on the clinician’s mobile device. The shorthand clinical note created helps the clinician complete more comprehensive documentation at a later time.  

“Our development of emerging technologies like voice recognition will help arm clinicians with tools that empower them to more fully engage with their patients and deliver smarter care,” said Dr. Tanuj Gupta, vice president and physician executive, Cerner Intelligence. “We’re tapping into our renowned history and expertise in health care technology to set the pace of advancement in the industry. Through our agile iterative approach, we’re bringing new innovation to our clients faster than before with the goal of making care delivery easier for clinicians and simpler for patients.”

With its 500th issued patent, Cerner has signaled a competitive edge in supporting clients through the next era of health care digitization. The company’s strong commitment to R&D is proof of its dedication to bringing forth new technologies that improve clinician and patient experiences and revolutionize how care is delivered. Leveraging its legacy of innovation and disruption, Cerner continues to seek new ways to build on top of the platforms it created and develop new solutions to shape the future of health care.

Cerner’s patent program is constantly evolving to address health care’s macro trends and advance the way clients deliver care. The company is exploring additional patents that support the migration of data to the cloud, intelligence and analytics to improve clinician and patient experiences, and predictive analytics and AI to improve health outcomes.

About Cerner
Cerner’s health technologies connect people and information systems at more than 27,500 contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers integrated clinical and financial systems to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit Cerner.com, The Cerner Blog, The Cerner Podcast or connect on Facebook, Instagram,  LinkedIn or  Twitter. Nasdaq: CERN. Smarter Care. Better Outcomes. Healthier You. 

Media Contacts:
Cerner
Austin Cozzolino, Public Relations, (816) 786-2154, [email protected] 

Primary Logo




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter